BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3477744)

  • 1. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide.
    Eisenbud L; Horowitz I; Kay B
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):289-92. PubMed ID: 3477744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thalidomide in the treatment of aphthosis and Behçet's disease. 4 years' experience].
    Torras H; Lecha M; Mascaró/ JM
    Med Cutan Ibero Lat Am; 1982; 10(2):103-112. PubMed ID: 6759802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
    Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S
    Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of Apremilast in idiopathic recurrent aphthous stomatitis: Review of two clinical cases].
    Fourmond S; Gutierrez B; Gourin MP; Delaumenie S; Ly KH
    Rev Med Interne; 2022 May; 43(5):312-315. PubMed ID: 35219509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in Behçet's disease.
    Shek LP; Lim DL
    Biomed Pharmacother; 2002 Feb; 56(1):31-5. PubMed ID: 11908493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Apremilast for Aphthous Ulcers in a Patient With Behçet’s Syndrome.
    Saini A; Ferguson C; Salkey K
    J Drugs Dermatol; 2018 Dec; 17(12):1328-1329. PubMed ID: 30586267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent aphthosis: safety of low dose thalidomide].
    Gil H; Perrin S; Dupond JL; Meaux-Ruault N; Hafsaoui C; Limat S; Magy-Bertrand N
    Rev Med Interne; 2010 Jun; 31(6):403-5. PubMed ID: 20430488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of aphthosis with thalidomide and with colchicine].
    Genvo MF; Faure M; Thivolet J
    Dermatologica; 1984; 168(4):182-8. PubMed ID: 6724071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide responsiveness in an infant with Behçet's syndrome.
    Shek LP; Lee YS; Lee BW; Lehman TJ
    Pediatrics; 1999 Jun; 103(6 Pt 1):1295-7. PubMed ID: 10353947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis.
    Mascaro JM; Lecha M; Torras H
    Arch Dermatol; 1979 May; 115(5):636-7. PubMed ID: 443847
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of recurrent oral aphthous ulcers with etanercept.
    Scheinberg MA
    Clin Exp Rheumatol; 2002; 20(5):733-4. PubMed ID: 12412213
    [No Abstract]   [Full Text] [Related]  

  • 12. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide.
    Letsinger JA; McCarty MA; Jorizzo JL
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):500-8. PubMed ID: 15761429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recurrent aphthous stomatitis case due to paediatric Behçet's disease.
    Unal M; Yildirim SV; Akbaba M
    J Laryngol Otol; 2001 Jul; 115(7):576-7. PubMed ID: 11485594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
    Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
    Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet's syndrome.
    Yildirim B; Oztürk MA; Unal S
    Rheumatol Int; 2009 Feb; 29(4):477-8. PubMed ID: 18802701
    [No Abstract]   [Full Text] [Related]  

  • 17. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
    Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C
    Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide: current and potential clinical applications.
    Calabrese L; Fleischer AB
    Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can therapeutic considerations provide clues to the etiology of aphthous stomatitis and Behçet's syndrome?
    Rytel MW
    J Oral Pathol; 1978; 7(6):372-5. PubMed ID: 105095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent giant aphthous ulcers in a child: protracted treatment with thalidomide.
    Menni S; Imondi D; Brancaleone W; Croci S
    Pediatr Dermatol; 1993 Sep; 10(3):283-5. PubMed ID: 8415309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.